Yuen Thomas C K - Net Worth and Insider Trading

Yuen Thomas C K Net Worth

The estimated net worth of Yuen Thomas C K is at least $24 Million dollars as of 2024-11-10. Yuen Thomas C K is the Director of DTS Inc and owns about 556,438 shares of DTS Inc (DTSI) stock worth over $24 Million. Details can be seen in Yuen Thomas C K's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Yuen Thomas C K has not made any transactions after 2012-08-22 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Yuen Thomas C K

Yuen Thomas C K Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Yuen Thomas C K owns 1 companies in total, including PharmaCyte Biotech Inc (PMCB) .

Click here to see the complete history of Yuen Thomas C K’s form 4 insider trades.

Insider Ownership Summary of Yuen Thomas C K

Ticker	Comapny	Transaction Date	Type of Owner
PMCB	PharmaCyte Biotech Inc	2021-08-10	director

Yuen Thomas C K Latest Holdings Summary

Yuen Thomas C K currently owns a total of 1 stock. Yuen Thomas C K owns 556,438 shares of DTS Inc (DTSI) as of August 22, 2012, with a value of $24 Million.

Latest Holdings of Yuen Thomas C K

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
DTSI	DTS Inc	2012-08-22	556,438	42.52	23,659,744

Holding Weightings of Yuen Thomas C K

Yuen Thomas C K Form 4 Trading Tracker

According to the SEC Form 4 filings, Yuen Thomas C K has made a total of 0 transactions in DTS Inc (DTSI) over the past 5 years. The most-recent trade in DTS Inc is the sale of 0 shares on August 22, 2012, which brought Yuen Thomas C K around $0.

Insider Trading History of Yuen Thomas C K

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Yuen Thomas C K Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Yuen Thomas C K Ownership Network

Ownership Network List of Yuen Thomas C K

No Data

Ownership Network Relation of Yuen Thomas C K

Yuen Thomas C K Owned Company Details

What does PharmaCyte Biotech Inc do?

Who are the key executives at PharmaCyte Biotech Inc?

Yuen Thomas C K is the director of PharmaCyte Biotech Inc. Other key executives at PharmaCyte Biotech Inc include director & CFO Carlos Trujillo , director & Chairman & CEO & Pres and GC Kenneth L. Waggoner , and director & Chief Science Officer Gerald W Crabtree .

PharmaCyte Biotech Inc (PMCB) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of PharmaCyte Biotech Inc (PMCB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of PharmaCyte Biotech Inc (PMCB) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

PharmaCyte Biotech Inc (PMCB)'s detailed insider trading history can be found in Insider Trading Tracker table.

PharmaCyte Biotech Inc Insider Transactions

No Available Data

Yuen Thomas C K Mailing Address

Above is the net worth, insider trading, and ownership report for Yuen Thomas C K. Currently GuruFocus does not have mailing address information for Yuen Thomas C K.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.